January 2024 : A patient taking semaglutide presented with gastroparesis which greatly improved when she stopped taking the medication
Residues within the Transmembrane Domain of the Glucagon-Like Peptide-1 Receptor Involved in Ligand Binding and Receptor Activation: Modelling the Ligand-Bound Receptor
Grow them together in a dish and you can watch it happen ( Belzer et al., 2017 )(Laboratory co-culture study)
7, 2025 Journal of Obesity, A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity, May 10, 2024 KFF, Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford, Nov
This has led to ethical concerns, as the increased demand helped create a shortage of these drugs around the world in recent months
But it also helps you feel full for longer